Tag Archives: Innovation Challenge

Call for Innovation Challenge Applicants

17 Jul

Life Science Nation invites all eligible early stage life science companies to apply to Innovation Challenge to showcase their technologies.

Companies from all categories of life science are encouraged to apply to Innovation Challenge for RESI Healthtech Week. Eligible companies can apply to Day 1, the First Coast Innovator’s Gathering, Day 2 RESI Global Partnering or both. Applicants will have the opportunity for excellent visibility among investors and strategic partners.

LSN is now accepting applications! The deadline is July 27, 2018.

For the first time this fall, Life Science Nation will have two days of Innovation Challenge competition as part of the RESI Healthtech Week (September 5-7, 2018). The Innovation Challenge offers selected companies the chance to gain more visibility from the early-stage investors in attendance.

Day 2 Redefining Early Stage Investments

All early-stage life science companies are eligible to apply. Finalists will be highlighted in multiple outlets:

  • Your country and technology highlighted at the conference
  • All conference attendees will have the chance to “invest” RESI Cash in their favorite technologies
  • LSN Newsletter Announcement to a readership of 20,000+
  • Featured on RESI Conference website Featured in the printed and online program guide
  • Winners will be announced during the cocktail reception
  • It is FREE to apply, click here.

Day 1, First Coast Innovation Challenge

All early-stage life science companies from DC through Boston are eligible to apply. Applicants will be highlighted in multiple outlets:

  • 10 finalists will be selected to pitch to a panel of investors
  • Applicants present a poster of their technology
  • All featured in the printed and online program guide
  • Attendees have access to partnering platform
  • Attendees have access to early-stage investor panels
  • Attendance on Day 1 for companies is $300, click here.

9 Hamilton Place, Suite 2B, Boston, MA 02108 +1 617-600-0668 | resi@lifesciencenation.com

RESI Healthtech Week Announces the First Coast Innovation Challenge on September 5th, And the RESI Global Innovation Challenge on September 6th

21 Jun

By Samuel Rubin, Business Development Manager, LSN

For the first time this fall, Life Science Nation (LSN) will have two days of competition as part of the RESI Healthtech Week (September 5-7, 2018). Day 1 will feature the First Coast Innovation Challenge, where the top 10 ranked companies of the First Coast tech hubs will present their technology as a 10-minute pitch to a panel of early-stage investors. Day 2 features the traditional RESI Innovation Challenge, where the top 30 companies who apply are chosen to showcase a poster on the RESI Global Partnering Conference Exhibit Hall.

LSN is proud to now include presentation opportunities for top technologies from the First Coast that have recently moved out of the lab and are ready to target grant, angel, and seed funding. The First Coast Innovation Challenge on Day 1 complements the RESI Global Innovation Challenge on Day 2, offering greater investor exposure to companies from the earliest stage to more established startups that are looking globally and seeking funding from institutional investors.

Applying for the Innovation Challenge at RESI Healthtech Week Will Boost Your Exposure with Investors

Those selected to be Innovation Challenge finalists will have the potential to dramatically increase the number of meaningful investor relationships they build. The objective of most early-stage companies and tech hubs attending RESI Healthtech Week is to have one-on-one meetings with investors who are a fit for them. The Innovation Challenge expands on the RESI Partnering Forum, providing an avenue to directly showcase to the whole investor audience, in addition to booking formal one-on-one meeting opportunities. Investors attending RESI Healthtech Week know that Innovation Challenge finalists are selected based on credentials for success and will be inclined to engage with these companies.

First Coast Innovation Challenge VS RESI Global Innovation Challenge

All registered attendees who qualify for Day 1 – First Coast Innovation Challenge are also eligible to apply for Day 2 – RESI Global Innovation Challenge. You must be a Qualifying First Coast Day 1 registrant to apply for the First Coast Innovation Challenge.

Qualifying Day 1 First Coast Innovation Challenge participants are the constituents of northeast corridor incubators, accelerators, tech transfer offices, university translation initiatives, hospitals, and research labs. Day 2 is open to all global attendees – scientist-entrepreneurs, fundraising CEOs, and the First Coast.

Selected finalists on Day 1 will pitch to global investors, while the selected Day 2 finalists will showcase their poster in the exhibit hall and will be eligible for the prizes awarded to the top Day 2 participants.

Innovation Challenge Application Open Now!

The online application for the Innovation Challenge officially opens today! We welcome applications both for Day 1 – First Coast Innovation Challenge, and Day 2 – RESI Global Innovation Challenge. The application deadline is Friday July 27, 2018 for both competitions.

If you are accepted as a finalist, we will notify you by Thursday August 9th, and you will have until Thursday August 16th to confirm your participation and register for RESI Healthtech Week.

The LSN Review Team and the 300+ investors attending RESI Healthtech Week look forward to learning more about your unique technologies!

 

 

RESI Innovation Challenge: Meet The Asia-Based Startups That Took The Top Spots At RESI Boston Summer

7 Jun

By Jessica Yang, Investor Research Analyst, LSN

On June 4th, more than 700 scientist-entrepreneurs and investors entered the exhibition hall at Boston Marriott Copley Place to participate in the RESI conference. They were greeted by 30 Innovation Challenge finalists across therapeutics, medical device, diagnostics, and digital health sectors. The 30 companies, evaluated by LSN’s expert system and scientific & commercial review team, competed directly on merits of innovation and commercial viability. We wish all our finalists the best in bringing their products forward toward commercialization, but there could only be 3 top prize winners.

First Prize: Taiwan Resonant Waves Research Corp.

Taiwan Resonant Waves Research Corp. (TRWR) was founded in 2010 in the capital of Taiwan – Taipei. Integrating innovative bioelectronic technology with non-invasive medical devices, we are dedicated to helping patients with chronic diseases better manage health-related challenges.There is unlimited promise in the application of Bioelectrical medicine in the treatment of chronic diseases. Designed and developed by TRWR, Microcurrent Electrical Nerve Stimulation technology (MENS) is currently being used as a non-invasive, physical approach to treating and alleviating symptoms associated with diabetes (such as decreasing HbA1c of Type 2 Diabetes Mellitus patient). Our vision is to lead the world in groundbreaking research and development in electroceutical technology as a means of enhancing quality of life, without the adverse side effects of conventional approaches.

Natasha Eldridge, Director of RESI Conference Series, LSN | Lucy Parkinson, Director of Investor Research, LSN | Chris Chen, Business Development, TRWR | Ann Chiu, COO, TRWR | Kuo-Chuan Huang, Doctor, TRWR

Second Prize: The Wave Talk

Our laser-based sensor is many times more accurate than conventional laser and is able to detect even low concentrations of bacteria based on its movements in real-time. Even though our first application targets water, we have managed to decrease antibiotics susceptibility test from 10-15 hours to less than 1 hour.

Natasha Eldridge, Director of RESI Conference Series, LSN | Lucy Parkinson, Director of Investor Research, LSN | SeungA LEE, Marketing, UX, The Wave Talk | YoungDug Kim, CEO & Founder, The Wave Talk

Third Prize: Taipeibio

Taipeibio is an R&D-driven company with core technology derived from Harvard and MIT; which focuses on tissue regeneration and repairs various bone defects including alveolar bone, bone, joint, ligament and cartilage. Taipeibio has comprehensive global IP protection in over 45 countries (Fish & Richardson; Cesari & McKenna). Taipeibio has established 3 core labs and 5 research arms to support product development with 2 governmental funding programs . Taipeibio has accumulated over 160 successful clinical cases with 14 years stress-bearing data to prove safety and efficacy. The cartilage regeneration product has been proved to repair large articular cartilages and difficult TMJ defects in a rabbit model. Relative scientific reports were published in high-impact SCI journals. The products will be made in U.S.A. and aiming FDA approval.

Natasha Eldridge, Director of RESI Conference Series, LSN | Lucy Parkinson, Director of Investor Research, LSN | Dr. Thomas Wen-Fu Lai, TaipeiBio | Jim-Pei Chu, CEO, TaipeiBio

It is worth mentioning that the proportion of Asia-based startups at RESI is the highest it’s ever been. LSN worked closely with both Development Center of Biotechnology (DCB) from Taiwan and Korea Trade-Investment Promotion Agency (KOTRA).  Of the over 100 startups that applied to be finalists in the RESI Innovation Challenge, more than 30% were from Taiwan or Korea.  This is also the first time that Asia-based companies won all three top prizes. The first and third place winners were two Medtech companies from Taiwan, Taiwan Resonant Waves Research Corp and TaipeiBio respectively. The second place winner was THE WAVE TALK, one of the Korea-based companies sponsored by KOTRA. Check out how RESI collaborates with KOTRA.

%d bloggers like this: